Skip to main content
. 2020 Dec 10;12(23):2109–2123. doi: 10.2217/epi-2020-0236

Table 6. . Significant probes common between diagnosed and presymptomatic dementia groups.

Probe Probe Location Timepoint Status Mean (%) Δ Case versus controls p-value
APP cg08542030 chr21:27306498 Baseline Control 76.66% 1.41% 0.02
        Presymptomatic 78.07%    
      Follow-up Control 75.36% 2.39% 0.01
        Dementia 77.75%    
  cg17728373 chr21:27404776 Baseline Control 58.34% 2.16% 0.03
        Presymptomatic 60.51%    
      Follow-up Control 57.07% 3.86% 0.01
        Dementia 60.92%    
  cg22552084 chr21:27497496 Baseline Control 61.80% 1.90% 0.03
        Presymptomatic 63.69%    
      Follow-up Control 61.16% 2.68% 0.03
        Dementia 63.84%    
  cg03015479 chr21:27544797 Baseline Control 68.09% 1.82% 0.04
        Presymptomatic 69.91%    
      Follow-up Control 66.64% 3.32% 0.007
        Dementia 69.96%    
BDNF cg26949694 chr11:27742060 Baseline Control 17.86% -1.05% 0.03
        Presymptomatic 16.82%    
      Follow-up Control 19.00% -2.30% 0.03
        Dementia 16.69%    
  cg01225698 chr11:27742355 Baseline Control 11.70% -1.05% 0.02
        Presymptomatic 10.66%    
      Follow-up Control 12.29% -1.83% 0.02
        Dementia 10.47%    
  cg27351358 chr11:27743258 Baseline Control 8.13% -0.92% 0.02
        Presymptomatic 7.21%    
      Follow-up Control 8.33% -1.39% 0.01
        Dementia 6.94%    
SNCA cg06176111 chr4:90674837 Baseline Control 62.15% 1.57% 0.05
        Presymptomatic 63.72%    
      Follow-up Control 61.87% 2.48% 0.04
        Dementia 64.34%    
  cg17045024 chr4:90758207 Baseline Control 18.89% -1.89% 0.04
        Presymptomatic 17.00%    
      Follow-up Control 19.72% -3.36% 0.03
        Dementia 16.36%    
  cg00119181 chr4:90758537 Baseline Control 8.40% -1.20% 0.05
        Presymptomatic 7.21%    
      Follow-up Control 9.53% -2.34% 0.02
        Dementia 7.20%